Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
20.09
-0.91 (-4.33%)
Dec 3, 2024, 4:00 PM EST - Market closed
Viridian Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Dec '24 Dec 3, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 1,591 | 1,145 | 1,176 | 429 | 64 | 15 | |
Market Cap Growth | 159.31% | -2.58% | 173.76% | 568.00% | 321.43% | -83.67% | |
Enterprise Value | 1,050 | 989 | 892 | 379 | 44 | -9 | |
Last Close Price | 20.09 | 21.78 | 29.21 | 19.77 | 16.45 | 7.20 | |
PS Ratio | 5752.02 | 3647.53 | 663.46 | 144.94 | 61.23 | 3.42 | |
PB Ratio | 3.07 | 2.59 | 2.98 | 2.29 | 0.54 | 0.97 | |
P/TBV Ratio | 3.35 | 4.86 | 4.65 | 7.97 | - | 0.97 | |
EV/Sales Ratio | 3477.82 | 3150.76 | 503.65 | 127.79 | 41.48 | - | |
Debt / Equity Ratio | 0.03 | 0.05 | 0.01 | 0.00 | 0.00 | 0.53 | |
Asset Turnover | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | 0.09 | |
Quick Ratio | 18.21 | 17.93 | 12.73 | 14.48 | 11.96 | 2.67 | |
Current Ratio | 18.55 | 18.26 | 12.93 | 14.68 | 12.14 | 2.92 | |
Return on Equity (ROE) | -51.88% | -56.80% | -44.57% | -51.61% | -163.07% | -124.81% | |
Return on Assets (ROA) | -32.14% | -34.37% | -26.28% | -29.75% | -31.36% | -51.84% | |
Return on Capital (ROIC) | -34.14% | -36.80% | -28.52% | -32.28% | -35.04% | -58.31% | |
Earnings Yield | -16.15% | -20.76% | -11.05% | -18.49% | -172.21% | -274.49% | |
FCF Yield | -12.41% | -16.16% | -8.05% | -12.79% | -46.39% | -236.90% | |
Buyback Yield / Dilution | -42.07% | -39.48% | -169.22% | -235.07% | -70.27% | -5.87% | |
Total Shareholder Return | -42.07% | -39.48% | -169.22% | -235.07% | -70.27% | -5.87% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.